Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 32.65M P/E - EPS this Y 37.30% Ern Qtrly Grth -
Income -9.57M Forward P/E -9.27 EPS next Y 21.60% 50D Avg Chg -3.00%
Sales 51.87M PEG -0.27 EPS past 5Y -28.70% 200D Avg Chg -7.00%
Dividend N/A Price/Book 2.06 EPS next 5Y 30.00% 52W High Chg -42.00%
Recommedations 3.00 Quick Ratio 1.29 Shares Outstanding 16.25M 52W Low Chg 16.00%
Insider Own 25.00% ROA -16.30% Shares Float 12.27M Beta 0.82
Inst Own 20.13% ROE -71.54% Shares Shorted/Prior 330.79K/314.26K Price 2.04
Gross Margin 42.04% Profit Margin -18.45% Avg. Volume 12,787 Target Price 2.00
Oper. Margin -24.73% Earnings Date May 9 Volume 8,329 Change -0.49%
About IRIDEX Corporation

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

IRIDEX Corporation News
09:39 AM IRIDEX Corporation (NASDAQ:IRIX) Q4 2023 Earnings Call Transcript
09:10 AM Q4 2023 IRIDEX Corp Earnings Call
03/26/24 Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
03/26/24 Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
03/20/24 Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
02/22/24 Zacks Industry Outlook Highlights MicroVision, Cutera and IRIDEX
02/21/24 3 Laser Systems Stocks to Watch in a Challenging Industry
02/14/24 We're Keeping An Eye On IRIDEX's (NASDAQ:IRIX) Cash Burn Rate
02/06/24 Iridex Corporation Receives European Patent on MicroPulse Technology
01/24/24 Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
01/11/24 Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
12/28/23 Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
09:00 AM Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
11/14/23 Iridex Reports Third Quarter 2023 Financial Results and Business Update
11/13/23 Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
10/26/23 Iridex to Report Third Quarter Financial Results on November 14, 2023
10/10/23 IRIDEX's (NASDAQ:IRIX) growing losses don't faze investors as the stock surges 18% this past week
08/29/23 Iridex Announces Strategic Review to Unlock Shareholder Value
08/11/23 Q2 2023 IRIDEX Corp Earnings Call
08/10/23 Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates
IRIX Chatroom

User Image qwertylicious2003 Posted - 1 day ago

$IRIX let’s cook this bird already

User Image firewire11 Posted - 3 days ago

$IRIX 🔥🔥🔥

User Image ricericebaby111 Posted - 4 days ago

@DH_Explorer I increased my position on $IRIX after the earnings report. I increased my position on $TPCS after the Votaw merger failure. I increased my position in $QIPT after the huge drop in share price. I currently DO NOT own any $ALAR.

User Image idkmikes57 Posted - 1 week ago

$IRIX why the fall this wasn't $9 stock and 2020?

User Image laste_rounde Posted - 2 weeks ago

$IRIX Added some today. Looking for 100% ish from here

User Image ricericebaby111 Posted - 2 weeks ago

$LLAP - If you guys are looking for another company thats about to get bought out, take a look at $IRIX. They are already in talks with mutiple companies. They confirmed it in their last earnings call. I have huge positions in both $LLAP and $IRIX because of these possible acquisitions.

User Image Stocks4thought Posted - 2 weeks ago

$IRIX Why did it go up?

User Image Doozio Posted - 2 weeks ago

$IRIX chop chop huckleberries. Let’s bang bro. It’s 🧠⏰

User Image laste_rounde Posted - 2 weeks ago

$IRIX Acting well. Let's close this thing team. Hoping for 6.5-7.5

User Image 1inTheStink Posted - 2 weeks ago

$IRIX always too early on calls. Ahhhhhwell

User Image firewire11 Posted - 2 weeks ago

$IRIX 🔥🔥🔥

User Image DH_Explorer Posted - 2 weeks ago

$IRIX This is just beginning to move- think about it... SEVERAL buyers at this low/mid $3 price- still-.... WHY? It's going to $6+ with sooner than later impending news. HOLD on to it for 2x (or 3 bagger for some of us!)

User Image RollingDollar Posted - 2 weeks ago

$IRIX

User Image qwertylicious2003 Posted - 3 weeks ago

$IRIX let’s sell this already

User Image laste_rounde Posted - 3 weeks ago

$IRIX Soon coming "sooner" ?!

User Image laste_rounde Posted - 3 weeks ago

$IRIX Nice relative strength today. Ready for that deal close (s)

User Image DH_Explorer Posted - 3 weeks ago

$EDR #benmagidson I feel the same- I was expecting the mid $30's- $36 actually...The deal is expected to close in the first quarter of 2025. Instead of waiting that long for my "premium" I'm gonna sell and take my money and put it into $IRIX. Now THAT will be a premium when they sell half their company!!! ($3 to $6+)

User Image DH_Explorer Posted - 03/28/24

$IRIX gotta keep buying this...20-30% so far is nothing. This stock is $5-$6.50 easy....

User Image 1inTheStink Posted - 4 weeks ago

$IRIX

User Image _StockTrader Posted - 4 weeks ago

Real-Time Stock Data $IRIX Price: 2.95 Volume: 137794 Market Cap: 45981272 PE Ratio: -10.884616 Powered by: BNNHF

User Image _StockTrader Posted - 4 weeks ago

Real-Time Stock Data $IRIX Price: 2.95 Volume: 132888 Market Cap: 46793664 PE Ratio: -11.076924 Powered by: BNNHF

User Image RollingDollar Posted - 1 month ago

$IRIX

User Image laste_rounde Posted - 1 month ago

$IRIX Feels like both units getting sold but multiple buyers with one group a little out front in the process

User Image Tyo7 Posted - 1 month ago

$IRIX when is "soon"

User Image epsguid Posted - 1 month ago

$IRIX reported a loss of $0.18, consensus was ($0.05) via @eWhispers #epsmiss http://eps.sh/d/irix

User Image laste_rounde Posted - 1 month ago

$IRIX Added in after hours Sale "soon"

User Image Stock_Titan Posted - 1 month ago

$IRIX Iridex Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/IRIX/iridex-reports-fourth-quarter-and-full-year-2023-financial-oth754f91982.html

User Image Tyo7 Posted - 1 month ago

$IRIX tick tock... 🙏🏻🚀

User Image firewire11 Posted - 1 month ago

$IRIX signs of life 🔥🔥🔥

User Image 1inTheStink Posted - 1 month ago

$IRIX

Analyst Ratings
Stifel Hold Aug 26, 22
Roth Capital Buy May 12, 21
Roth Capital Buy Mar 3, 21
Roth Capital Buy Jan 13, 21
Stifel Buy May 12, 20
Stifel Buy Jan 4, 19
Stifel Buy Oct 26, 18
Roth Capital Buy Dec 21, 16
Singular Research Buy Jan 26, 16
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Devi Nandini Director Director May 20 Buy 3.0999 2,000 6,200 10,420 05/23/22
Devi Nandini Director Director Mar 16 Buy 4.20 2,000 8,400 8,420 03/16/22